This annual educational symposium is proud to update our medical community on the state-of-the-art care of gastric cancer and gastrointestinal stromal tumors, while focusing on the importance of a multidisciplinary approach to the diagnosis and treatment of these rare and complicated disease entities. National and international renowned and distinguished faculty, including those from MedStar Health and MedStar Georgetown Cancer Institute will discuss the significant roles of evolving new diagnostic modalities, immune, regional, and molecular targeted therapies, the use of organ-sparing surgery, and the use of state-of-the art radiotherapeutics in these rare and complex cancers. This symposium will also highlight evolving role of palliative surgery for advanced gastric cancer. Finally, this symposium will host a case presentation panel to shed light on the controversies around the management of gastroesophageal cancers.

1. Discuss novel imaging techniques for gastric neoplasms.
2. Identify the diagnostic and therapeutic role of endoscopy in gastric tumors.
3. Recognize the importance of molecular markers in the diagnosis and treatment of gastric neoplasms.
4. Identify novel radiotherapeutic targeted and immune therapies for gastric neuroendocrine tumors (NETs) and soft tissue sarcomas.
5. Recognize the role and indications for radiation therapy, including proton beam therapy, in the treatment of soft tissue sarcomas.
6. Implement best practices in managing "lumps and bumps" vs. soft tissue sarcomas by primary care providers and general surgeons.
7. Identify the various treatment options for limb-preserving surgery in persons with extremity soft tissue sarcomas.
8. Identify the landscape of different mutations for gastrointestinal stromal tumor (GIST) and their implications for management and treatment.
9. Discuss the new drugs being evaluated for the treatment of patients with advanced recurrent GIST.
10. Review the indications for surgical treatment of different stages of GIST.

• Physician $100
• Resident and Fellow $75
• Physician Assistant $75
• Nurse Practitioner $75
• Nurse $75
• Allied Health Professional $75
• Industry Professional $200

In support of improving patient care, MedStar Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Designation

This activity was planned by and for the healthcare team, and learners will receive 5.5 Interprofessional Continuing Education (IPCE) credits for learning and change.

Physicians: MedStar Health designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: This activity is approved for 5.5 ANCC contact hour(s). Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants: MedStar Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 5.5 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.